Urban-gro, Inc. UGRO reported its financial results Thursday for the third quarter ended Sept. 30, 2023, revealing a 69% year-over-year and 11% sequential increase in total revenues to $20.9 million.
“Since launching our sector diversification initiative just over a year ago, urban-gro has successfully evolved into a multi-sector focused professional services consulting firm,” said Bradley Nattrass, chairman and CEO of the Colorado-based company.
Q3 2023 Financial Highlights
- Gross profit totaled $2.8 million, up from $2.6 million in the prior year’s period.
- Loss from operations amounted to $3.1 million, down from $6.9 million in the third quarter of last year.
- Net loss amounted to $3.4 million, representing an improvement of $5.3 million versus the prior year period and a sequential improvement of $2.1 million.
- Adjusted EBITDA came in negative at $1.3 million, representing an improvement of $1 million versus the prior year period and a sequential improvement of $0.7 million.
- Project backlog of $84 million as of September 30, 2023, representing a sequential increase of $5 million, or 6%.
- As of Sept. 30, 2023, the company had $58.6 million in total assets, down from $62 million on Dec. 31, 2022.
Q4 2023 Guidance
The company also provided a fourth-quarter 2023 guidance of approximately $30 million in revenues and breakeven to slightly positive adjusted EBITDA.
“Our strengthening revenue and adjusted EBITDA performance in the third quarter reflects a solid improvement on both a sequential and year-over-year basis,” Nattrass explained. “Given our strengthening pipeline and backlog, we continue to anticipate sequential quarterly improvement as we work to recapture positive Adjusted EBITDA generation.”
UGRO Price Action
urban-gro’s shares traded 1.54% higher at $1.32 per share at the time of writing on Friday morning.
Related News
Ancillary Cannabis Business Ramps Up Market Presence With $3M In Marijuana Contracts
Urban-gro Secures Over $2M In Deal With XS Financial, What's Next?
Photo: Courtesy of Josh Appel on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.